Rubedo Life Sciences | AI | Standout | Standout

Rubedo Life Sciences

2 employees

Series A · $52.0M

Company details

Team Size2

IndustryAI

Funding

Total raised

$52.0M

Last stage

Series A

Investors

Khosla Ventures

Ahren Innovation Capital

Alumni Ventures

StandoutYBacked by Y Combinator · P26

“LeBron has an agent. Why don’t you?”

— Now you have one too.

Earn $3,000

ProductHow it works For talent For companies Browse jobs Browse companies

CompanyAbout Blog Careers

ConnectTwitter / X LinkedIn

Standout.

Privacy Terms

The Longevity Fund

Catalio Capital

Founders

Marco Quarta

Scientist, entrepreneur, and biotechnology executive focused on aging and regenerative medicine. Previously led research at Stanford University's Center for Tissue Regeneration. Founding CEO of Rubedo (2018–2024), now CSO.

Mark Gallop

Veteran drug hunter, chemist, and serial entrepreneur. Former CSO at BlueLight Therapeutics and President at Light Horse Therapeutics. Expert in drug discovery in oncology, neuroscience, and GI disorders.

Julian Klein

Co-founder at Rubedo Life Sciences, based in the San Francisco Bay Area. Background in early-stage biotech and drug development.

What happens next.

No applications, no recruiter spam. Just the intro.

Confirm the fit

A few questions to make sure this role is the right shape for you. Two minutes.

I pitch you to the company

I write the intro, send it to the founder, and handle the back-and-forth.

A meeting lands on your calendar

If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.